Recurrent Osteosarcoma Not Yet Recruiting Phase 2 Trials for Ivosidenib (DB14568)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs